
Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences
(Reuters) - Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to...
18th February, 2025

(Reuters) - Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to...
18th February, 2025

By Ernest Scheyder and Lewis Jackson (Reuters) - A Chinese company has stopped exporting a piece of...
18th February, 2025

WARSAW (Reuters) - Polish border guards discovered over 100 kg of cocaine on the bottom of the Balti...
18th February, 2025

BERLIN (Reuters) - German automotive supplier ZDF is considering a spin-of of its electric drive tra...
18th February, 2025

AMSTERDAM - Dutch energy storage firm Return plans to build a 1.4 gigawatt battery storage facility...
18th February, 2025

DUBLIN (Reuters) - Irish food ingredients multinational Kerry Group has a policy of producing locall...
18th February, 2025

By Pietro Lombardi MADRID (Reuters) - Spanish gas grid operator Enagas plans to invest more than 4 b...
18th February, 2025

(Reuters) - French industrial gases company Air Liquide on Tuesday announced a joint investment with...
18th February, 2025

By Nick Carey LONDON (Reuters) - British startup Ionetic, which develops electric vehicle battery pa...
18th February, 2025

By Marie Mannes STOCKHOLM (Reuters) - Sweden's Northvolt has agreed to sell a business that makes el...
18th February, 2025

By Nikita Maria Jino (Reuters) - Britain's Airport Coordination Limited (ACL) won a government-led t...
18th February, 2025

By Nellie Peyton JOHANNESBURG (Reuters) - South African lab technician Nozipho Mlotshwa was waiting...
18th February, 2025